FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Whitepaper

Financing Social Good – What the RBC Social Finance Initiative Has Taught Us

Admin Aug 28, 2026
Featured News

Fintech Enters a New Era as AI, Real-Time Payments and Embedded…

Whitepaper

New global retail banking data

Articles

India’s Fintech Market Crash: Is the Boom Turning Into a Reality…

Articles

Can Blockchain Revolutionize the Banking System?

Whitepaper

Why financial institutions need one-to-one messaging to build profitable customer…

Admin Aug 24, 2026
By taking advantage of today’s technologically advanced world, there are many opportunities for financial…
Featured News

Rising Grocery Prices Put Pressure on Indian Household Budgets as Food Inflation…

Admin Aug 21, 2026
India’s household budgets are coming under renewed pressure as rising prices of everyday groceries, vegetables,…
Featured News

Gold and Silver Prices Surge as Investors Turn to Precious Metals Amid Global…

Admin Aug 20, 2026
Gold and silver prices have once again moved higher in India, highlighting the continued strength and volatility…
Featured News

AI and Intelligent Payments Reshape the FinTech Industry in 2026

Admin Aug 18, 2026
The global FinTech industry is entering a new phase of transformation in 2026 as artificial intelligence,…
Featured News

Rising Tax Burden and Public Frustration: When Government Taxation Becomes a Daily…

Admin Aug 17, 2026
Government taxation remains one of the most important sources of public revenue, funding infrastructure,…
Featured News

FinTech’s Next Growth Wave: AI, Embedded Finance and Digital Trust Reshape the…

Admin Aug 14, 2026
The global FinTech industry is entering a new phase of transformation as artificial intelligence, embedded…
Whitepaper

Future of Finance: Review on the outlook for the UK financial system

Admin Aug 13, 2026
The Governor asked me last year to lead a review of the future of the UK’s financial system, and what it might…
Articles

FinTech and Employee F&F Settlement: How Digital Financial Platforms Are…

Admin Aug 12, 2026
The financial technology, or FinTech, industry is transforming the way businesses manage money, payments, payroll,…
Articles

How AI and Digital Innovation Are Transforming the Future of the FinTech Industry

Admin Aug 11, 2026
The financial technology industry is entering a new era. What began as a movement to make banking and payments…
Whitepaper

The Power of Ecosystems for Banking

Admin Aug 10, 2026
The rise of Banking as a Service (BaaS) and real-time payments (RTP) are pushing the era of digitalization to new…
Articles

The Rise of Fintech: Transforming the Financial Landscape

Admin Aug 7, 2026
Fintech, short for financial technology, refers to the innovative application of technology in financial…
Articles

Why Financial Services and Banks Need an Operational Data Layer

Admin Aug 5, 2026
Unlocking Real-Time Intelligence for the Future of Financial Services The financial services industry is…
Articles

FinTech Futures: How Media, Advertising & Marketing Are Shaping the Next…

Admin Aug 4, 2026
Introduction: Finance Is No Longer Just About Banking The financial services industry has undergone a…
Articles

Fintech and the Stock Market: How Technology Is Revolutionizing Modern Investing

Admin Aug 3, 2026
Discover how fintech is transforming the stock market through AI, algorithmic trading, robo-advisors, blockchain,…
Whitepaper

Shifting focus Risk culture is at the forefront of banking

Admin Jul 31, 2026
The new message this year is the almost universal focus on risk culture, with an emphasis on conduct, reflecting…
Whitepaper

Future of Banking Industry

Admin Jul 30, 2026
There may not be many striking features in this scenario, but let’s see what processes are running behind the…
Articles

Blockchain and Its Most Useful Applications in Finance

Admin Jul 29, 2026
Blockchain technology is notable for its transparent database, safe data, decentralized network, and cryptographic…
Articles

FinTech: Definition, Advantages of the FinTech Movement, and More

Admin Jul 28, 2026
The financial services industry is undergoing a profound transformation, driven by a wave of innovation and new…
Articles

Utilizing Procurement Tools for Businesses in the Modern Era

Admin Jul 27, 2026
In today’s fast-paced business landscape, effective procurement processes are pivotal for maintaining a…
Articles

How Fintech is Revolutionizing Personal Finance Management

Admin Jul 24, 2026
Financial technology (fintech) has dramatically changed the landscape of personal finance, offering consumers more…
Whitepaper

The Modernization of Payments and the New Bank Tech Company

Admin Jul 23, 2026
The writing is on the wall. Disruptive technologies, evolving consumer behaviors and expectations, innovative new…
Whitepaper

Central Bank Digital Currency Global Interoperability Principles

Admin Jul 21, 2026
Central banks have different motivations for exploring or developing central bank digital currency (CBDC), and the…
Articles

How to Calculate the Effect of Physical Risks on Finance

Admin Jul 20, 2026
Acute physical risks from climate change can be caused by storms or floods, or they can be chronic, resulting from…
Articles

Five things not to do while financial planning

Admin Jul 17, 2026
Many women rely on their parents or spouses for financial planning and investment responsibilities because it has…
Whitepaper

Artificial Intelligence, Machine Learning and Big Data in Finance

Admin Jul 16, 2026
Artificial Intelligence (AI) techniques are being increasingly deployed in finance, in areas such as asset…
Whitepaper

Plan Sponsor Reporting and Audit Guide

Admin Jul 15, 2026
Unlike many trusteed plans, a retirement plan using TIAA and CREF annuities may be funded, in whole or in part, by…
Whitepaper

Real-time payments: A perspective for payment system policy makers

Admin Jul 14, 2026
As the name suggests, real-time payment systems accelerate the speed at which funds are transferred between…
Articles

The Share Market and Systematic Investment Plans (SIPs): A Guide to Smart…

Admin Jul 13, 2026
The share market has long been a significant avenue for individuals seeking to build wealth through…
Whitepaper

Scaling Your Property Management Business With Payment Technology

Admin Jul 10, 2026
Property management is an industry that has seen steady yet significant growth over the past year. Obviously, the…
Articles

Banks slash interest rates on home loans: should you move your balance?

Admin Jul 9, 2026
Two banks, Bank of Baroda and Bank of Maharashtra, have recently reduced their interest rates for home loans amid…
Featured News

Figure Technologies Launches Ready Life Partnership to Increase Mortgage Access

Admin Jul 3, 2026
Figure Technologies, Inc., a leader in transforming financial services through the power of blockchain technology,…
Whitepaper

Building a Greenfield Digital Bank in the Fintech Era

Admin Jul 1, 2026
Gone are the days when customers would visit brick and mortar stores 3-5 times a week to complete their daily…
1 2 3 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Financing Social Good – What the RBC Social Finance Initiative Has Taught Us
    • Fintech Enters a New Era as AI, Real-Time Payments and Embedded Finance Reshape Global Financial Services
    • New global retail banking data
    • India’s Fintech Market Crash: Is the Boom Turning Into a Reality Check?
    • Can Blockchain Revolutionize the Banking System?

    ARTICLE

    KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
    2026-10-24T09:00:00Z
    RIYADH, Saudi Arabia, Oct. 24, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is widening patients’ access to emergency expertise beyond its physical departments. Its virtual...


    Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
    2026-10-24T08:15:00Z
    BOSTON, Oct. 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the publication...


    Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
    2026-10-24T08:15:00Z
    Median PFS was 21.5 months with the gedatolisib triplet and 11.5 months with the gedatolisib doublet versus 9.1 months with alpelisib + fulvestrant in patients who had no liver metastases


    Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
    2026-10-24T06:35:00Z
    ORION CORPORATION PRESS RELEASE 24 OCTOBER 2026 at 9.35 EEST


    Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
    2026-10-24T06:30:00Z
    Houston, Texas and Tuebingen, Germany, October 24, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning...


    Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
    2026-10-24T06:30:00Z
    VANCOUVER, British Columbia, Oct. 24, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel,...


    Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
    2026-10-24T03:30:32Z
    SHANGHAI, China, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and...


    RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
    2026-10-24T00:00:00Z
    ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of...


    J-Star Holding Co., Ltd. Files Interim Financial Report on Form 6-K
    2026-10-23T20:15:00Z
    Company is Highlighting Strategic Focus on U.S. Opportunities, Balance Sheet Improvement, and Management Commitment


    The Ensign Group Schedules Third Quarter 2026 Earnings Call for Wednesday, October 28, 2026
    2026-10-23T20:01:00Z
    SAN JUAN CAPISTRANO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled...


    Climb Bio and Mabworks Announce CLYM116/MIL116 Data Demonstrating Deep, Durable APRIL Suppression and ~70% Gd-IgA1 Reduction at ASN Kidney Week 2026
    2026-10-23T20:01:00Z
    >90% free APRIL suppression sustained through 12 weeks, supporting Q12W dosing interval


    Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders
    2026-10-23T20:01:00Z
    Real-world analysis showed serum phosphate reductions following XPHOZAH initiation across all phosphate binder groups evaluated


    ArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026
    2026-10-23T20:00:00Z
    NEWTOWN SQUARE, Pa., Oct. 23, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics,...


    Beyond Elizabeth Holmes: Ryan El Hosseiny Thanks Nathan Fielder for Shining a Light on Cancer Research
    2026-10-23T19:21:52Z
    MIAMI, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Featured as “The Billboard Guy” in Nathan Fielder's documentary, You Can See Everything, biochemist, entrepreneur and Just Blood founder Ryan El Hosseiny welcomes...


    SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
    2026-10-23T19:01:27Z
    BRUSSELS, Oct. 23, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced results from the Post-Authorisation Efficacy Study (PAES)...


    Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
    2026-10-23T17:30:00Z
    Basel, 23 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today late-breaking oral presentation data from the ongoing phase III IMAgINATION study in adults with primary IgA nephropathy...


    NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
    2026-10-23T17:01:32Z
    Price barriers are falling, as improving technicals meet a string of clinical, international, and regulatory milestones with November 17’s FDA meeting next on the calendar.


    Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
    2026-10-23T15:55:00Z
    Company Announcement


    Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026
    2026-10-23T15:45:00Z
    Daridorexant, a dual orexin receptor antagonist, is the first investigational treatment in its class to demonstrate positive results in pediatric insomnia disorder, an area in which significant unmet needs remain...


    Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
    2026-10-23T15:45:00Z
    Basel, October 23, 2026 – Novartis today presented positive results from the pivotal Phase III REMODEL-1 and REMODEL-2 trials in relapsing multiple sclerosis (RMS) showing that remibrutinib, a highly selective...


    KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells
    2026-10-23T15:00:00Z
    RIYADH, Saudi Arabia, Oct. 23, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is advancing gene therapy for sickle cell disease through a 2026 clinical trial...


    Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026
    2026-10-23T14:30:00Z
    Single-dose miv-cel continues to demonstrate promising clinical benefit in progressive multiple sclerosis, achieving robust CAR T-cell penetration in the central nervous system (CNS) and improving disability scores while removing the...


    How Peptide Conjugate Developability Is Shaped Before a Candidate Is Nominated
    2026-10-23T14:30:00Z
    San Diego, CA, Oct. 23, 2026 (GLOBE NEWSWIRE) -- There are about 106 peptide and nanobody drug conjugates in active development, and around 63% of them are still preclinical, according...


    Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
    2026-10-23T14:15:00Z
    62.5% Confirmed Objective Response Rate (ORR) and 29.2% Complete Response (CR) Rate in Final Phase 2 Analysis


    Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026
    2026-10-23T14:15:00Z
    SAN DIEGO, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach...


    XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers
    2026-10-23T13:17:07Z
    AUSTIN, Texas, Oct. 23, 2026 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today announced that its Board of Directors have elected Jan-Paul Simard to serve as Co-Chief Executive Officer alongside...


    MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
    2026-10-23T13:15:00Z
    ROCKVILLE, MD, Oct. 23, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced positive...


    Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026
    2026-10-23T13:15:00Z
    -- Prolonged Stable Disease: PAS-004 achieved prolonged stable disease in a heavily pre-treated population, with four patients on PAS-004 for more than 300 days, including two who continue on once...


    Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress
    2026-10-23T13:15:00Z
    MILLBRAE, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs,...


    Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer
    2026-10-23T13:15:00Z
    BOSTON, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Precede Biosciences, a company powering next-generation precision medicine through its functional liquid biopsy platform, today announced new data being presented at the European...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.